IBDEI1RI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29948,1,1,0)
 ;;=1^J9395
 ;;^UTILITY(U,$J,358.3,29948,1,3,0)
 ;;=3^Fulvestrant 25mg
 ;;^UTILITY(U,$J,358.3,29949,0)
 ;;=90471^^116^1487^1^^^^1
 ;;^UTILITY(U,$J,358.3,29949,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29949,1,1,0)
 ;;=1^90471
 ;;^UTILITY(U,$J,358.3,29949,1,3,0)
 ;;=3^Immunization Admin,1 Vaccine
 ;;^UTILITY(U,$J,358.3,29950,0)
 ;;=90472^^116^1487^2^^^^1
 ;;^UTILITY(U,$J,358.3,29950,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29950,1,1,0)
 ;;=1^90472
 ;;^UTILITY(U,$J,358.3,29950,1,3,0)
 ;;=3^Immunization Admin,Ea Addl Vaccine
 ;;^UTILITY(U,$J,358.3,29951,0)
 ;;=90658^^116^1488^2^^^^1
 ;;^UTILITY(U,$J,358.3,29951,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29951,1,1,0)
 ;;=1^90658
 ;;^UTILITY(U,$J,358.3,29951,1,3,0)
 ;;=3^Flu Vaccine
 ;;^UTILITY(U,$J,358.3,29952,0)
 ;;=90632^^116^1488^4^^^^1
 ;;^UTILITY(U,$J,358.3,29952,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29952,1,1,0)
 ;;=1^90632
 ;;^UTILITY(U,$J,358.3,29952,1,3,0)
 ;;=3^Hepatitis A Vaccine
 ;;^UTILITY(U,$J,358.3,29953,0)
 ;;=90636^^116^1488^3^^^^1
 ;;^UTILITY(U,$J,358.3,29953,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29953,1,1,0)
 ;;=1^90636
 ;;^UTILITY(U,$J,358.3,29953,1,3,0)
 ;;=3^Hepatitis A & B Vaccine
 ;;^UTILITY(U,$J,358.3,29954,0)
 ;;=90746^^116^1488^5^^^^1
 ;;^UTILITY(U,$J,358.3,29954,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29954,1,1,0)
 ;;=1^90746
 ;;^UTILITY(U,$J,358.3,29954,1,3,0)
 ;;=3^Hepatitis B Vaccine
 ;;^UTILITY(U,$J,358.3,29955,0)
 ;;=90732^^116^1488^6^^^^1
 ;;^UTILITY(U,$J,358.3,29955,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29955,1,1,0)
 ;;=1^90732
 ;;^UTILITY(U,$J,358.3,29955,1,3,0)
 ;;=3^Pneumococcal Vaccine
 ;;^UTILITY(U,$J,358.3,29956,0)
 ;;=90723^^116^1488^1^^^^1
 ;;^UTILITY(U,$J,358.3,29956,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29956,1,1,0)
 ;;=1^90723
 ;;^UTILITY(U,$J,358.3,29956,1,3,0)
 ;;=3^DTaP-HepB-IPV Vaccine
 ;;^UTILITY(U,$J,358.3,29957,0)
 ;;=99358^^116^1489^3^^^^1
 ;;^UTILITY(U,$J,358.3,29957,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29957,1,1,0)
 ;;=1^99358
 ;;^UTILITY(U,$J,358.3,29957,1,3,0)
 ;;=3^Prolong Srv w/o Pt Contact,1st Hr
 ;;^UTILITY(U,$J,358.3,29958,0)
 ;;=99359^^116^1489^4^^^^1
 ;;^UTILITY(U,$J,358.3,29958,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29958,1,1,0)
 ;;=1^99359
 ;;^UTILITY(U,$J,358.3,29958,1,3,0)
 ;;=3^Prolong Srv w/o Pt Contact,Ea Addl 30 Min
 ;;^UTILITY(U,$J,358.3,29959,0)
 ;;=99354^^116^1489^1^^^^1
 ;;^UTILITY(U,$J,358.3,29959,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29959,1,1,0)
 ;;=1^99354
 ;;^UTILITY(U,$J,358.3,29959,1,3,0)
 ;;=3^Outpt E&M Prolonged Svc,1st Hr
 ;;^UTILITY(U,$J,358.3,29960,0)
 ;;=99355^^116^1489^2^^^^1
 ;;^UTILITY(U,$J,358.3,29960,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29960,1,1,0)
 ;;=1^99355
 ;;^UTILITY(U,$J,358.3,29960,1,3,0)
 ;;=3^Outpt E&M Prolonged Svc,Ea Addl 30 Min
 ;;^UTILITY(U,$J,358.3,29961,0)
 ;;=99201^^117^1490^1
 ;;^UTILITY(U,$J,358.3,29961,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,29961,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,29961,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,29962,0)
 ;;=99202^^117^1490^2
 ;;^UTILITY(U,$J,358.3,29962,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,29962,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,29962,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,29963,0)
 ;;=99203^^117^1490^3
 ;;^UTILITY(U,$J,358.3,29963,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,29963,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,29963,1,2,0)
 ;;=2^99203
 ;;^UTILITY(U,$J,358.3,29964,0)
 ;;=99204^^117^1490^4
 ;;^UTILITY(U,$J,358.3,29964,1,0)
 ;;=^358.31IA^2^2
